The report provides a detailed analysis essential for establishing a butenafine production plant. It encompasses all critical aspects necessary for butenafine production, including the cost of butenafine production, butenafine plant cost, butenafine production costs, and the overall butenafine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a butenafine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Butenafine is a synthetic antifungal compound that is mainly used for treating skin infections caused by fungi. It is widely used in topical medicines for the treatment of fungal skin infections like athlete’s foot, ringworm, and jock itch. It works by stopping the growth of fungi, which helps relieve itching, redness, and scaling of the skin. In some cases, it is also used in combination therapies to improve results in resistant skin infections. It is commonly formulated into creams and gels meant for external use. Moreover, it is also used in pharmaceutical research for studying antifungal activity and developing new skin treatments. It serves as an important component in dermatology due to its targeted action against fungal infections and good patient tolerance.
The primary factor that drives the market for butenafine is its demand as an antifungal agent to relieve itching, redness, and discomfort linked with various dermatological infections. Its application as a reliable option in topical antifungal treatment for conditions like athlete’s foot and ringworm significantly promotes its demand in the medical and pharmaceutical industries. Its usage as a topical medication for the treatment of other dermatological fungal infections, such as tinea cruris (jock itch) and tinea versicolor, further drives its demand in the dermatology sector. Its demand in the healthcare sector for its fast action and long-lasting effects, allowing for shorter treatment periods compared to other antifungal creams, further boosts its market growth.
Additionally, industrial butenafine procurement is influenced by factors such as cost and availability of active pharmaceutical ingredients, adherence to pharmaceutical-grade production standards, regulatory approvals, and consistency in supply. Technological improvements in formulation development, focus on clean-label and skin-safe ingredients, and efficient global distribution channels also play a vital role in shaping the procurement and market trends for butenafine worldwide.
Raw Material for Butenafine Production
According to the butenafine production plant project report, the major raw materials for butenafine production include N-Methyl-1-naphthylmethylamine hydrochloride, dry dimethylformamide, anhydrous sodium carbonate, p-tert-Butylbenzyl bromide, and hydrochloric acid.
Production Process of Butenafine
The extensive butenafine production cost report consists of the following industrial production process:
- Production from Naphthalene-based amine salt: The production process of butenafine hydrochloride begins with dissolving N-Methyl-1-naphthylmethylamine hydrochloride in dry dimethylformamide, followed by the addition of anhydrous sodium carbonate to form a basic medium. Then, p-tert-Butylbenzyl bromide is introduced, and the reaction mixture is stirred and maintained at a mild temperature for several hours to promote alkylation. After completion, the mixture is treated with water and extracted using toluene. The organic layer is washed, and the solvent is removed to yield a crude product. This is purified through silica gel column chromatography using a mixture of ethyl acetate and n-hexane. The purified oily intermediate is then treated with hydrochloric acid in ethanol and crystallised from a methanol-acetic acid mixture to form butenafine hydrochloride as the final product.
Butenafine is a synthetic benzylamine antifungal agent that acts by inhibiting the enzyme squalene epoxidase, thereby disrupting the synthesis of ergosterol required for fungal cell membranes. It appears as an odourless white crystalline powder. The molecular formula of the compound is C23H27N, and its molar mass is 317.47 g/mol. Its density is approximately 1.032 g/cm³, and it has a melting point of 200–202 °C. The boiling point of the compound is approximately 426.1 °C. It is insoluble in water but is freely soluble in methanol, ethanol, chloroform, and dimethyl sulfoxide (DMSO). It has a LogP value of 6.770, which indicates high lipophilicity, which contributes to its effectiveness in penetrating skin layers for topical antifungal treatment. In addition to its antifungal properties, butenafine also exhibits anti-inflammatory activity, which is beneficial as fungal skin infections are often accompanied by significant inflammation. It is recommended to avoid contact with the eyes, mucous membranes, and open wounds while using formulations containing this compound. Protective measures should be taken during the handling of the raw substance.